Previous close | 264.90 |
Open | 264.90 |
Bid | 264.80 x 0 |
Ask | 282.40 x 0 |
Day's range | 264.90 - 264.90 |
52-week range | 185.25 - 290.60 |
Volume | |
Avg. volume | 14 |
Market cap | 96.319B |
Beta (5Y monthly) | 0.26 |
PE ratio (TTM) | 41.85 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 27.27% and 16.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Swedish Orphan Biovitrum (BIOVF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is how Alcon (ALC) and Swedish Orphan Biovitrum (BIOVF) have performed compared to their sector so far this year.